For 2021, 71 percent of surveyed investment professionals expect that biopharmaceutical companies will target early stage, highly innovative assets. This statistic illustrates the percentage of expected acquisitions by biopharmaceutical companies in 2021, by type of asset.
Expected targets of biopharmaceutical acquisitions in 2021, by asset type
Characteristic
Percentage of companies
Early stage, highly innovative assets
71%
Late stage assets with greater certainty of near-term revenue
39%
Full company acquisitions that will diversify the commercial portfolio
29%
Interested in significantly sized acquisition/ merger
29%
Commercial stage assets
23%
Full company acquisitions of pre-revenue biotechs that provide an innovative platform
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
KPMG. (March 27, 2021). Expected targets of biopharmaceutical acquisitions in 2021, by asset type [Graph]. In Statista. Retrieved November 23, 2024, from https://www.statista.com/statistics/1240055/expected-acquisitions-by-biopharma-industry-by-asset/
KPMG. "Expected targets of biopharmaceutical acquisitions in 2021, by asset type." Chart. March 27, 2021. Statista. Accessed November 23, 2024. https://www.statista.com/statistics/1240055/expected-acquisitions-by-biopharma-industry-by-asset/
KPMG. (2021). Expected targets of biopharmaceutical acquisitions in 2021, by asset type. Statista. Statista Inc.. Accessed: November 23, 2024. https://www.statista.com/statistics/1240055/expected-acquisitions-by-biopharma-industry-by-asset/
KPMG. "Expected Targets of Biopharmaceutical Acquisitions in 2021, by Asset Type." Statista, Statista Inc., 27 Mar 2021, https://www.statista.com/statistics/1240055/expected-acquisitions-by-biopharma-industry-by-asset/
KPMG, Expected targets of biopharmaceutical acquisitions in 2021, by asset type Statista, https://www.statista.com/statistics/1240055/expected-acquisitions-by-biopharma-industry-by-asset/ (last visited November 23, 2024)
Expected targets of biopharmaceutical acquisitions in 2021, by asset type [Graph], KPMG, March 27, 2021. [Online]. Available: https://www.statista.com/statistics/1240055/expected-acquisitions-by-biopharma-industry-by-asset/
